XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 11,339,032 $ 4,739,426
Accounts receivable, net of allowance for credit losses of $0 2,022,518 673,071
Prepaid expenses 146,704 885,040
Inventories 493,408 481,840
Other current assets 36,421 47,532
Total current assets 14,038,083 6,826,909
Deferred offering costs 115,488 241,637
Total assets 14,153,571 7,068,546
Current liabilities:    
Accounts payable and accrued expenses 2,188,164 1,711,778
Accrued compensation 590,634 1,324,010
Note payable 5,000,000 5,000,000
Accrued interest payable 1,987,637 1,612,295
Total current liabilities 9,766,435 9,648,083
Total liabilities 9,766,435 9,648,083
Commitments and contingencies
Stockholders' equity (deficit):    
Preferred stock, $0.0001 par value; authorized shares - 5,000,000 as of September 30, 2024 and December 31, 2023; issued and outstanding shares - zero as of September 30, 2024 and December 31, 2023 0 0
Common stock, $0.0001 par value; authorized shares - 100,000,000 and 50,000,000 as of September 30, 2024 and December 31, 2023, respectively; issued and outstanding shares - 894,843 and 278,558 as of September 30, 2024 and December 31, 2023, respectively 89 28
Additional paid-in capital 131,985,913 120,859,873
Accumulated deficit (127,598,866) (123,439,438)
Total stockholders' equity (deficit) 4,387,136 (2,579,537)
Total liabilities and stockholders' equity (deficit) $ 14,153,571 $ 7,068,546